AIFA – Comunicazione EMA su medicinali a base di acidi grassi omega-3
10/4/2019
Leggi
Breaking news
Intermediate hyperglycaemia to predict progression to type 2 diabetes (ELSA-Brasil): an occupational cohort study in Brazil
Schmidt MI, Bracco PA, Yudkin JS, et al.
Lancet Diabetes Endocrinol. 2019;7(4):267-7
Leggi
Exploring the association between BMI and mortality in Australian women and men with and without diabetes: the AusDiab study
Zahir SF, Griffin A, Veerman JL, et al.
Diabetologia. 2019;62:754-8
Leggi
Alcohol consumption and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) study
He X, Rebholz CM, Daya N, et al.
Diabetologia. 2019;62:770-8
Leggi
Lean mass, grip strength and risk of type 2 diabetes: a bi-directional Mendelian randomisation study
Yeung CHC, Au Yeung SL, Fong SSM, et al.
Diabetologia. 2019;62:789-99
Leggi
Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial
Løvvik TS, Carlsen SM, Salvesen O, et al.
The Lancet Diabetes &Endocrinology. Pub. online 1 April 2019
Leggi
Fully closed-loop insulin delivery in inpatients receiving nutritional support: a two-centre, open-label, randomised controlled trial
Boughton CK, Bally L, Martignoni F, et al.
The Lancet Diabetes &Endocrinology. Pub. online 29 March 2019
Leggi
Contribution of specific diseases and injuries to changes in health adjusted life expectancy in 187 countries from 1990 to 2013: retrospective observational study
Chen H, Chen G, Zheng X, et al.
BMJ. 2019;364:l969
Leggi
The future of the GLP-1 receptor agonists
Hirsch IB
JAMA. Pub. online 23 March 2019
Leggi
Effect of additional oral semaglutide vs sitagliptin on glycated hemoglobin in adults with type 2 diabetes uncontrolled with metformin alone or with sulfonylurea – The PIONEER 3 Randomized Clinical Trial
Rosenstock J, Allison D, Birkenfeld AL, et al.
JAMA. Pub. online 23 March 2019
Leggi